Insomnia Relief with Neurostimulator Device – Modius Sleep
Neurovalens’ Modius Sleep is a neurostimulator device, FDA-cleared to combat chronic insomnia non-invasively. Learn more about this health-tech advancement.
Overview
Neurovalens is a health-tech company that specializes in non-invasive neurostimulation products, headquartered in Belfast. The company develops technologies aimed at addressing significant health challenges. Its Modius technology is FDA-cleared and uses small electrical pulses to influence deep brain areas without the need for surgical implantation. Neurovalens is preparing to launch several versions of its technology to treat various disorders, with Modius Sleep being the first product set to release in October 2024. Modius Sleep is a physician-prescribed device designed to improve sleep for patients suffering from chronic insomnia. It is worn as a headset for 30 minutes each evening and employs electrical vestibular nerve stimulation (VeNS) to stimulate sleep neurons in the brain. The device uses self-adhesive electrode pads placed behind each ear to deliver safe electrical pulses that affect the hypothalamus and brainstem, which are crucial for regulating circadian rhythms and sleep patterns.
Details
- Category
- Medical Equipment Manufacturing
- Headquarters
- Belfast
- Type
- Privately Held
- Founded
- 2013
- Specialties
- Neurostimulation, Neuroendocrine, Hypothalamus, health, technology, Sleep, Stress, and Type 2 Diabetes
- Locations
- Belfast, GB
Funding
Total rounds: 11
Last round: Series unknown, Sep 19, 2025
Last round amount: US$ 6.8M